Meatly has secured £10.4 million in Series A funding, building on £7 million in prior seed investment for a total of £17.4 million. This capital will fund the construction of Europe's largest 20,000-litre bioreactor facility in London, aiming for product releases in 2027. Investors in this round include Oyster Bay Venture Capital, Clean Growth Fund, and JamJar Investments, following their earlier regulatory authorization and the sale of the world's first cultivated pet food.
